Literature DB >> 18599604

Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model.

Klaas Koop1, Michael Eikmans, Markus Wehland, Hans Baelde, Daphne Ijpelaar, Reinhold Kreutz, Hiroshi Kawachi, Dontscho Kerjaschki, Emile de Heer, Jan Anthonie Bruijn.   

Abstract

To evaluate changes during the development of proteinuria, podocyte morphology and protein expression were evaluated in spontaneously proteinuric, Dahl salt-sensitive (Dahl SS) rats. Dahl SS rats on a low-salt diet were compared with spontaneously hypertensive rats (SHR) at age 2, 4, 6, 8, and 10 weeks. Blood pressure, urinary protein excretion, urinary albumin excretion, and podocyte morphology were evaluated. In addition, the expression of 11 podocyte-related proteins was determined by analyzing protein and mRNA levels. In Dahl SS rats, proteinuria became evident around week 5, increasing thereafter. SHR rats remained non-proteinuric. Dahl SS rats showed widespread foot process effacement at 10 weeks. At < or =8 weeks, expression and distribution of the podocyte proteins was similar between the two strains, except for the protein podoplanin. At 4 weeks, podoplanin began decreasing in the glomeruli of Dahl SS rats in a focal and segmental fashion. Podoplanin loss increased progressively and correlated with albuminuria (r = 0.8, P < 0.001). Double labeling experiments revealed increased expression of the podocyte stress marker desmin in glomerular areas where podoplanin was lost. Dahl SS rats did not show podoplanin gene mutations or decreased mRNA expression. Thus, podocyte morphology and the expression and distribution of most podocyte-specific proteins were normal in young Dahl SS rats, despite marked proteinuria. Our study suggests that decreased expression of podoplanin plays a role in the decrease of glomerular permselectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599604      PMCID: PMC2475770          DOI: 10.2353/ajpath.2008.080063

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Getting a foothold in nephrotic syndrome.

Authors:  S Somlo; P Mundel
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

2.  Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats.

Authors:  Daniela Macconi; Marina Ghilardi; Maria Enrica Bonassi; Ehab I Mohamed; Mauro Abbate; Francesca Colombi; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  J Am Soc Nephrol       Date:  2000-03       Impact factor: 10.121

3.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

Authors:  J M Kaplan; S H Kim; K N North; H Rennke; L A Correia; H Q Tong; B J Mathis; J C Rodríguez-Pérez; P G Allen; A H Beggs; M R Pollak
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

4.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome.

Authors:  N Boute; O Gribouval; S Roselli; F Benessy; H Lee; A Fuchshuber; K Dahan; M C Gubler; P Niaudet; C Antignac
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

5.  Effect of high NaCl diet on spontaneous hypertension in a genetic rat model with reduced nephron number.

Authors:  R Kreutz; L Kovacevic; A Schulz; L Rothermund; M Ketteler; M Paul
Journal:  J Hypertens       Date:  2000-06       Impact factor: 4.844

6.  Role of Rho-GTPases in complement-mediated glomerular epithelial cell injury.

Authors:  Hui Zhang; Andrey V Cybulsky; Lamine Aoudjit; Jianxin Zhu; Hongping Li; Nathalie Lamarche-Vane; Tomoko Takano
Journal:  Am J Physiol Renal Physiol       Date:  2007-03-20

7.  Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin.

Authors:  P S Topham; H Kawachi; S A Haydar; S Chugh; T A Addona; K B Charron; L B Holzman; M Shia; F Shimizu; D J Salant
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

8.  Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier.

Authors:  George Jarad; Jeanette Cunningham; Andrey S Shaw; Jeffrey H Miner
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

9.  Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome.

Authors:  M Kestilä; U Lenkkeri; M Männikkö; J Lamerdin; P McCready; H Putaala; V Ruotsalainen; T Morita; M Nissinen; R Herva; C E Kashtan; L Peltonen; C Holmberg; A Olsen; K Tryggvason
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

10.  Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes.

Authors:  F G Scholl; C Gamallo; S Vilaró; M Quintanilla
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

View more
  24 in total

1.  High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.

Authors:  Wen-Yu Chuang; Yu-Sun Chang; Yin-Kai Chao; Chi-Ju Yeh; Yun-Hen Liu; Chen-Kan Tseng; Hsien-Kun Chang; Yung-Liang Wan; Chuen Hsueh
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Phosphorylated mTOR expression correlates with podoplanin expression and high tumor grade in esophageal squamous cell carcinoma.

Authors:  Wen-Yu Chuang; Yu-Sun Chang; Yin-Kai Chao; Chi-Ju Yeh; Shir-Hwa Ueng; Chiu-Yueh Chang; Yun-Hen Liu; Chen-Kan Tseng; Hsien-Kun Chang; Yung-Liang Wan; Chuen Hsueh
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Urine podoplanin heralds the onset of ischemia-reperfusion injury of the kidney.

Authors:  Vivek Kasinath; Osman Arif Yilmam; Mayuko Uehara; Merve Yonar; Liwei Jiang; Xiaofei Li; Weiliang Qiu; Siawosh Eskandari; Takaharu Ichimura; Reza Abdi
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-13

4.  The expression of podoplanin and classic cadherins in the mouse brain.

Authors:  Chiaki Kaji; Miwa Tomooka; Yukinari Kato; Hiroshi Kojima; Yoshihiko Sawa
Journal:  J Anat       Date:  2012-02-21       Impact factor: 2.610

5.  Immunoelectron microscopic study of podoplanin localization in mouse salivary gland myoepithelium.

Authors:  Minoru Hata; Ikuko Amano; Eichi Tsuruga; Hiroshi Kojima; Yoshihiko Sawa
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

6.  Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs.

Authors:  Yuri Imaizumi; Ikuko Amano; Eichi Tsuruga; Hiroshi Kojima; Yoshihiko Sawa
Journal:  Acta Histochem Cytochem       Date:  2010-10-15       Impact factor: 1.938

7.  Semiautomated quantitative image analysis of glomerular immunohistochemistry markers desmin, vimentin, podocin, synaptopodin and WT-1 in acute and chronic rat kidney disease models.

Authors:  J Funk; V Ott; A Herrmann; W Rapp; S Raab; W Riboulet; A Vandjour; E Hainaut; A Benardeau; T Singer; B Jacobsen
Journal:  Histochem Cell Biol       Date:  2015-12-15       Impact factor: 4.304

8.  Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.

Authors:  Wen-Yu Chuang; Chi-Ju Yeh; Yin-Kai Chao; Yun-Hen Liu; Yu-Sun Chang; Chen-Kan Tseng; Hsien-Kun Chang; Yung-Liang Wan; Chuen Hsueh
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

9.  Cosmc-dependent mucin-type O-linked glycosylation is essential for podocyte function.

Authors:  Brian R Stotter; Brianna E Talbot; Diane E Capen; Nadine Artelt; Junwei Zeng; Yasuyuki Matsumoto; Nicole Endlich; Richard D Cummings; Johannes S Schlondorff
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-06

Review 10.  The physiological and pathophysiological roles of platelet CLEC-2.

Authors:  Leyre Navarro-Núñez; Stacey A Langan; Gerard B Nash; Steve P Watson
Journal:  Thromb Haemost       Date:  2013-03-28       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.